U.K-based firm Proteome Sciences eyes the niche for a non-animal sensitivity test. Cosmetics Europe names its SensiDerm assay a first priority for funding.
Funding for Proteome Sciences PLC’s SensiDerm multiplex assay could take the non-animal allergy sensitization test a step closer to validation in the EU, potentially filling a void created by the animal-testing ban.
Trade group Cosmetics Europe notified Proteome Sciences that its multiplex assay has been selected for inclusion in a first-priority set...
Create an account to read this article
Already a subscriber?
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
Joshi joins the parent company of Citeline, home of HBW Insight, to focus on AI, business harmonization and long-term growth.
A survey asks FDA staff to disclose whether DEI policies caused discrimination or resulted in disciplinary action against career employees over the past five years, but uses a web form that the general public also can access.
Haleon described the opening of a new oral care R&D facility in the UK as a “major investment reflecting our commitment to advancing science and innovation.”
